3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
3
INDIV
2
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Leukemia, Myeloid, Acute
115
Myelodysplastic Syndromes
109
Precursor Cell Lymphoblastic Leukemia-Lymphoma
95
Leukemia
74
Hodgkin Disease
73
Leukemia, Lymphocytic, Chronic, B-Cell
72
Multiple Myeloma
71
Lymphoma, Non-Hodgkin
71
Lymphoma
66
Myeloproliferative Disorders
54
Graft vs Host Disease
50
Lymphoma, Follicular
49
Lymphoma, Mantle-Cell
47
Leukemia, Myeloid, Accelerated Phase
47
Lymphoma, Large B-Cell, Diffuse
46
Congenital Abnormalities
46
Leukemia, Myelomonocytic, Chronic
44
Lymphoma, B-Cell, Marginal Zone
43
Hematologic Neoplasms
43
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
42
Leukemia, Myeloid, Chronic-Phase
41
Burkitt Lymphoma
40
Primary Myelofibrosis
39
Blast Crisis
38
Neoplasms, Plasma Cell
37
Lymphoma, Large-Cell, Immunoblastic
32
Waldenstrom Macroglobulinemia
25
Myelodysplastic-Myeloproliferative Diseases
24
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
24
Lymphoma, T-Cell, Cutaneous
23
Interventions
Rituximab
7
Pyridostigmine Bromide
5
Prednisone
5
efgartigimod alfa
4
Hizentra
4
telitacicept
3
Immunoglobulins, Intravenous
3
Cyclophosphamide
3
Azathioprine
3
thymoglobulin
2
fludarabine
2
Thymectomy
2
Steroids
2
Mycophenolic Acid
2
Data Collection
2
Blood Specimen Collection
2
zilucoplan
1
tofacitinib
1
tocilizumab
1
talquetamab
1
sargramostim
1
rozanolixizumab
1
prednylidene
1
gamma-Globulins
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
bu-zhong-yi-qi-tang
1
apraclonidine
1
Walk Test
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Myasthenia Gravis
×
Tacrolimus
×
Clear all
NCT04182984
2026-01-30
TREAT-OMG
Tang-Du Hospital
Recruiting
200 enrolled